Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McGill University

$27,000.00

The role of breast cancer extracellular vesicles in the modulation of the metastatic microenvironment

FY 2025-26

Summary
Breast cancer is the most commonly diagnosed cancer among women in Canada. While advancements in screening and treatment have resulted in a decline of breast cancer-related deaths since the 1980s, prognosis remains poor for those who progress to metastasis. It is understood that breast cancer metastasis is not random, with most cases occurring in the bone, liver, lung, or brain. However, the mechanism behind this process is not well defined. Growing evidence suggests that a population of lipid-bound nanoparticles called extracellular vesicles (EVs) are released from cancer cells and capable of homing to distant sites and modulating cell behaviour to support metastatic tumour development. To understand this process, we will isolate EVs from metastatic breast cancer cell lines each corresponding to a different metastatic site. We then aim to evaluate their functional impact on cells representative of each distant organ site and identify candidate proteins responsible for such changes. Since natural EVs are heterogeneous and laborious to isolate, we have developed EV-mimetic liposomes which can be loaded with specific proteins of interest. Through this approach, we aim to recapitulate the effect of natural EVs in synthetic EVs and assess their impact on metastasis in vivo. The findings of this project are key to further understanding the cascade of metastatic progression and defining the role of EVs therein. If we determine that EVs can be re-engineered to travel to different distant sites, our synthetic model has the potential to overcome the lack of site specificity in therapeutic drug delivery. This translational significance aligns with the urgent need for precision medicine approaches to combat metastatic breast cancer.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572979
Name
Reyes Raphaelle
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of breast cancer extracellular vesicles in the modulation of the metastatic microenvironment
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Breast Cancer; Cancer; Extracellular Vesicle; Metastasis; Molecular Biology; Organotropism
Abstract
Breast cancer is the most commonly diagnosed cancer among women in Canada. While advancements in screening and treatment have resulted in a decline of breast cancer-related deaths since the 1980s, prognosis remains poor for those who progress to metastasis. It is understood that breast cancer metastasis is not random, with most cases occurring in the bone, liver, lung, or brain. However, the mechanism behind this process is not well defined. Growing evidence suggests that a population of lipid-bound nanoparticles called extracellular vesicles (EVs) are released from cancer cells and capable of homing to distant sites and modulating cell behaviour to support metastatic tumour development. To understand this process, we will isolate EVs from metastatic breast cancer cell lines each corresponding to a different metastatic site. We then aim to evaluate their functional impact on cells representative of each distant organ site and identify candidate proteins responsible for such changes. Since natural EVs are heterogeneous and laborious to isolate, we have developed EV-mimetic liposomes which can be loaded with specific proteins of interest. Through this approach, we aim to recapitulate the effect of natural EVs in synthetic EVs and assess their impact on metastasis in vivo. The findings of this project are key to further understanding the cascade of metastatic progression and defining the role of EVs therein. If we determine that EVs can be re-engineered to travel to different distant sites, our synthetic model has the potential to overcome the lack of site specificity in therapeutic drug delivery. This translational significance aligns with the urgent need for precision medicine approaches to combat metastatic breast cancer.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Reyes, Raphaelle
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~